Management of Common Bacterial Infections – Evidence‑Based Recommendations

Acute Bacterial Rhinosinusitis (ABRS)

• Typical presentation includes nasal congestion or obstruction, purulent nasal discharge, facial pain or pressure, maxillary tooth pain, fever, headache, cough, and hyposmia/anosmia. 1
• Diagnosis is based on one of three temporal patterns: (1) persistent symptoms > 10 days without improvement; (2) severe illness with fever > 39 °C + purulent discharge + facial pain for ≥ 3 consecutive days; or (3) “double sickening” – worsening after an initial improvement of > 3 days. 2
• Routine sinus imaging is not recommended because its specificity is only ~61 % and it adds cost without improving outcomes. 1
• First‑line antimicrobial therapy: amoxicillin‑clavulanate 875 mg/125 mg PO twice daily (or 500 mg/125 mg three times daily) for 5–7 days. [2][3]
• Acceptable alternatives when β‑lactam allergy or intolerance exists: doxycycline or a respiratory fluoroquinolone (e.g., levofloxacin). 3
• Most ABRS episodes are viral and self‑limited, with spontaneous resolution in ≈ 7 days for the majority of patients. 1
• Antibiotics should be reserved only for the three clinical patterns listed above; indiscriminate use offers minimal benefit. [2][4]
• Number needed to treat (NNT) for rapid cure is 18, whereas the number needed to harm (NNH) from adverse drug effects is 8, underscoring the importance of selective prescribing. 4

Group A β‑Hemolytic Streptococcal (GABHS) Pharyngitis

• Classic symptoms: abrupt fever, severe sore throat, tonsillopharyngeal exudates, anterior cervical adenitis, red/swollen uvula, and absence of cough. 1
• Use the Centor or McIsaac criteria to decide who should undergo microbiologic testing (RADT or throat culture). 1
• Rapid Antigen Detection Test (RADT) and/or throat culture are required; antibiotics are indicated only if the test is positive. [1][5]
• First‑line therapy for confirmed infection: penicillin V 500 mg PO twice daily 10 days or amoxicillin 500 mg PO twice daily (or 1000 mg once daily) for 10 days. 5
• In patients with documented penicillin allergy, the preferred alternative is cefalexin; clarithromycin is an acceptable second line. 5
• Antibiotic treatment shortens symptom duration by 1–2 days and prevents serious sequelae such as rheumatic fever and peritonsillar abscess. [6][1]
• Up to 15 % of children are chronic carriers; they should not be treated because they have minimal risk of transmission or complications. 6

Acute Otitis Media (AOM)

• Watchful waiting (no immediate antibiotics) is appropriate for children > 2 years with unilateral, non‑severe AOM. 5

All statements are derived from peer‑reviewed evidence (e.g., Annals of Internal Medicine, Clinical Microbiology and Infection) and reflect the strength of the underlying data as presented in the source articles.

Evidence‑Based Management of Common Bacterial Infections

Acute Bacterial Rhinosinusitis (ABRS)

• Diagnostic criteria – ABRS is diagnosed when one of three patterns is present: (1) persistent symptoms > 10 days without improvement; (2) severe illness with fever > 39 °C, purulent nasal discharge, and facial pain for ≥ 3 consecutive days; or (3) “double sickening,” i.e., worsening after an initial improvement of > 3 days. 7
• First‑line antimicrobial therapy – Amoxicillin‑clavulanate 875 mg/125 mg orally twice daily for 5–7 days is recommended; doxycycline or a respiratory fluoroquinolone (e.g., levofloxacin) may be used in patients with β‑lactam allergy. 7
• Antibiotic prescribing patterns – More than 80 % of sinusitis visits result in antibiotic prescriptions, yet the majority are unnecessary. 7

Group A β‑Hemolytic Streptococcal (GABHS) Pharyngitis

• Testing and treatment algorithm – Clinicians should apply the Centor/McIsaac criteria to decide whether rapid antigen detection testing or throat culture is needed; antibiotics are indicated only when the test is positive. 7

Erysipelas

• Typical clinical presentation – Erysipelas manifests as a well‑demarcated, raised, erythematous, warm, tender skin lesion with sharp borders, most often on the face or lower extremities, accompanied by fever, chills, and malaise. 8

Antibiotic Stewardship Across Common Infections

• Need for judicious use – Careful antibiotic selection is essential to combat antimicrobial resistance; both the 2016 Annals of Internal Medicine guidance and the 2024 Clinical Microbiology and Infection recommendations emphasize this principle. [7][8]
• Acute otitis media (AOM) over‑treatment – Antibiotics are frequently overused in AOM, although most episodes resolve spontaneously without antimicrobial therapy. 8

Acute Bacterial Rhinosinusitis (ABRS) – Diagnosis and Treatment

Presentation

Typical symptoms include purulent nasal discharge, nasal obstruction, facial pain or pressure, maxillary tooth pain, fever, cough, and reduced sense of smell. 9

Diagnostic Criteria (clinical)

These criteria are endorsed by the American Academy of Pediatrics and the American Academy of Otolaryngology‑Head and Neck Surgery. [9][10]

Diagnostic Approach

ABRS is diagnosed *clinically only; routine imaging (plain radiographs or CT) is not recommended* unless complications such as orbital or intracranial involvement are suspected. [9][11]

First‑Line Antibiotic Therapy

Amoxicillin‑clavulanate 875 mg/125 mg orally twice daily for *5–7 days* (or 500 mg/125 mg three times daily) is the preferred regimen for uncomplicated ABRS. 12

Follow‑up and Re‑assessment

Patients should be re‑evaluated at *72 hours* if symptoms have not improved or have worsened; this timing is based on pediatric guideline recommendations. [9][12]

Acute Otitis Media (AOM) – Diagnosis and Management

Presentation

Common findings are ear pain, fever, irritability, decreased hearing, and a bulging or erythematous tympanic membrane with effusion. 13

Diagnostic Criteria (clinical)

Acute onset of middle‑ear effusion accompanied by at least one sign of inflammation (bulging tympanic membrane, otorrhea, or marked erythema). 13

Diagnostic Method

Diagnosis is made *clinically via otoscopy*; no additional laboratory testing is required. 13

Indications for Immediate Antibiotic Therapy

Immediate antibiotics are recommended for:
These criteria follow the American Academy of Pediatrics recommendations. 13

First‑Line Antibiotic Regimen

Amoxicillin 80–90 mg/kg/day orally divided twice daily for *5–10 days* (duration based on age and severity) is the standard initial therapy. 13

Group A β‑Hemolytic Streptococcal (GABHS) Pharyngitis – Confirmation and Treatment

Microbiologic Confirmation Required

Antibiotics should *only be prescribed after a positive rapid antigen detection test (RADT) or throat culture*; a negative RADT in children or adolescents must be followed by a confirmatory culture. 13

Recommended Antibiotic Course

Penicillin V 500 mg orally twice daily *for 10 days* (or amoxicillin 500 mg twice daily, or 1000 mg once daily for 10 days) is advised to prevent rheumatic fever, as emphasized by pediatric guidelines. 13

All recommendations reflect the consensus of the American Academy of Pediatrics (and related specialty societies where noted). Evidence levels were not explicitly stated in the cited sources.

Acute Bacterial Rhinosinusitis (ABRS)

Diagnostic Criteria

• Persistent symptoms > 10 days without improvement, severe onset (fever ≥ 39 °C + purulent nasal discharge ≥ 3 consecutive days), or worsening after an initial improvement define bacterial infection and indicate the need for antibiotics. 14
• Diagnosis is based on clinical assessment alone; routine imaging (e.g., sinus CT) is not recommended for uncomplicated cases. 14

Management Recommendations

• Antibiotics should be reserved only for the three diagnostic patterns above; otherwise, supportive care is advised. 14
• If no clinical improvement is observed, patients should be reassessed at 72 hours to decide whether to initiate antimicrobial therapy. 14

Group A Streptococcal (GABHS) Pharyngitis

Diagnostic Approach

• Apply the Centor/McIsaac scoring system to select patients for testing; a positive rapid antigen detection test (RADT) or throat culture confirms GABHS infection. 15, 16, 17, 18
• In children and adolescents, a negative RADT must be followed by a throat culture to exclude false‑negative results. 15, 16, 17, 18

Treatment Recommendations

• First‑line therapy: Penicillin V 500 mg orally twice daily for 10 days OR Amoxicillin 500 mg twice daily (or 1000 mg once daily) for 10 days; a 10‑day course is required to prevent acute rheumatic fever. 15
• Penicillin‑allergic patients (non‑anaphylactic): Cephalexin 500 mg twice daily or Clindamycin 300 mg three times daily or Azithromycin 500 mg once daily for 5 days. 15

Acute Bacterial Rhinosinusitis: Evidence‑Based Diagnosis and Management

Diagnostic Criteria

• Persistent nasal symptoms (purulent discharge, obstruction, facial pain/pressure) lasting ≥ 7 days without improvement meet the AAO‑HNS definition of acute bacterial rhinosinusitis (ABRS)【19】【20】.
• The presence of bilateral acute otitis media alongside sinus symptoms further supports a bacterial etiology and is a recognized complication of ABRS【21】.

Etiology and Differential Exclusion

Viral‑to‑Bacterial Progression

• Co‑habitant illness suggests an initial viral upper‑respiratory infection that has progressed to bacterial superinfection, the most common pathway to ABRS【22】.

Allergic Rhinitis

• Acute onset with infectious exposure, mucopurulent (not clear watery) discharge, and absence of sneezing, nasal itching, or ocular symptoms effectively rule out allergic rhinitis per AAO‑HNS criteria【23】.

Odontogenic Sinusitis

• Lack of maxillary dental pain, bilateral disease pattern, and no foul‑smelling drainage argue against odontogenic sinusitis, which typically presents unilaterally after dental infection or procedure【20】【22】.

Imaging Recommendations

• Routine sinus imaging (CT or plain radiographs) is not indicated in uncomplicated ABRS because radiographic abnormalities are present in up to 87 % of viral URI cases and do not alter management【19】【20】【24】.

Therapeutic Management

First‑Line Antibiotic

• Amoxicillin‑clavulanate 875 mg twice daily for 10 days is the recommended first‑line regimen for ABRS, preferred over amoxicillin alone by AAO‑HNS guidelines【19】【20】【21】.

Adjunctive Symptom Relief

• Guaifenesin (expectorant) may be used for symptomatic relief of cough and thickened secretions, though supporting evidence is limited【25】【26】.
• Alternating ibuprofen and acetaminophen provides effective analgesia for sinus‑related pain【19】【20】.
• Increased hydration helps thin secretions and improve drainage【26】.

Follow‑Up and Safety

• Arrange 72‑hour follow‑up (or sooner) if symptoms worsen or fail to improve, to identify treatment failure or complications【21】.
• Patients should complete the full 10‑day antibiotic course, even if symptoms resolve earlier, to reduce recurrence and antimicrobial resistance【19】.
• Provide return precautions (e.g., worsening pain, fever, visual changes) to ensure timely detection of complications【21】.

Clinical Pitfalls

• Do not rely on purulent nasal discharge alone to diagnose bacterial infection; the temporal pattern (≥ 10 days, worsening after initial improvement, or severe onset) is required for accurate classification【19】.

All statements are derived from peer‑reviewed evidence cited above and reflect current AAO‑HNS and American College of Radiology recommendations.

Management of Acute Bacterial Rhinosinusitis in Adults

Diagnostic Criteria

• The American Academy of Otolaryngology–Head and Neck Surgery defines acute bacterial rhinosinusitis (ABRS) as ≥ 3 consecutive days of purulent nasal discharge together with facial pain or pressure, meeting the “severe onset” pattern for bacterial infection【27】【28】.

First‑Line Antimicrobial Therapy

• The Infectious Diseases Society of America recommends amoxicillin‑clavulanate 875 mg/125 mg orally twice daily for 5–7 days as the preferred regimen for uncomplicated ABRS【28】.
• This combination is superior to amoxicillin alone because it reliably covers β‑lactamase‑producing Haemophilus influenzae and Moraxella catarrhalis【28】.
• Evidence shows a number needed to treat (NNT) of 18 for rapid clinical cure and a number needed to harm (NNH) of 8 for adverse effects, underscoring the need for accurate bacterial diagnosis before prescribing【28】.

Alternative Regimens for β‑Lactam Allergy

• For patients with documented β‑lactam allergy, doxycycline 100 mg twice daily or a respiratory fluoroquinolone such as levofloxacin 750 mg once daily is advised【28】.

Symptomatic Relief

• The American Academy of Otolaryngology–Head and Neck Surgery advises alternating ibuprofen 400–600 mg every 6 hours with acetaminophen 650–1000 mg every 6 hours to achieve superior analgesia for sinus pain and headache【27】.
• Saline nasal irrigation (hypertonic or isotonic) performed 2–3 times daily improves mucociliary clearance and reduces overall symptom burden【28】.
• Intranasal corticosteroids (e.g., fluticasone two sprays per nostril daily) may lessen mucosal inflammation, although evidence for an acute benefit is limited【28】.

Antimicrobial‑Related Adverse Effects

• Diarrhea is a common side effect of amoxicillin‑clavulanate, with an NNH of 8; patients should be counseled that this is expected and usually self‑limited【28】.

Follow‑Up and Safety‑Net

• If there is no clinical improvement by 7 days of therapy, reassessment for complications, alternative diagnoses, or antimicrobial resistance is recommended【28】.
• Persistent high fever (≥ 39 °C) beyond 48 hours of appropriate antibiotic treatment constitutes a red‑flag symptom that warrants immediate re‑evaluation【28】.

Levofloxacin Use in Acute Bacterial Sinusitis – Evidence‑Based Guidance

Indications and Alternative Therapies

• Levofloxacin should be reserved for patients with a documented β‑lactam allergy or intolerance, rather than used as first‑line therapy for acute bacterial sinusitis. 29
• Doxycycline is an acceptable alternative to β‑lactam agents for treating acute bacterial sinusitis when β‑lactams cannot be used. 29

Benefit‑Risk Balance

• In the treatment of acute bacterial sinusitis, the number needed to treat (NNT) to achieve rapid cure with any antibiotic is 18, while the number needed to harm (NNH) from adverse effects is 8, highlighting the modest absolute benefit and the importance of careful patient selection. 29

Diagnostic Criteria and Imaging

• Antibiotics should be prescribed only when at least one of the following criteria is met:
• Routine sinus imaging is not recommended because it adds cost and radiation exposure without improving diagnostic accuracy; its specificity for bacterial sinusitis is only about 61 %. 30

Fluoroquinolone Stewardship

• Levofloxacin (a fluoroquinolone) should not be used as first‑line therapy; it should be reserved to preserve its effectiveness against resistant pathogens and for severe infections. 29

Treatment Duration Recommendations

• For the 500 mg once‑daily levofloxacin regimen, the maximum recommended duration is 7 days; for the 750 mg once‑daily regimen, the maximum is 5 days. In real‑world practice, excessive durations occur in 75 % of first‑line and 63 % of second‑line antibiotic courses. 29